中文(简体)
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Emerging From the Haze for Gynecologic Cancer Survivors

只有注册用户可以翻译文章
登陆注册
链接已保存到剪贴板
状态已完成
赞助商
Cedars-Sinai Medical Center

关键词

抽象

At Cedars-Sinai Medical Center, the investigators have developed a novel curriculum for a 6-week psycho-educationally-based, cognitive behavioral program to help patients with subjective cognitive complaints after cancer treatment, titled Emerging from the Haze™ (Haze). Each series meets once a week for 2-2.5 hours for 6 weeks.
The objective of this study is to quantify the impact of a trainee-taught Emerging from the Haze course on gynecologic cancer survivors' self-report of cognitive changes based on the change of FACT-Cog score.

日期

最后验证: 12/31/2018
首次提交: 09/20/2016
提交的预估入学人数: 09/27/2016
首次发布: 09/28/2016
上次提交的更新: 01/01/2019
最近更新发布: 01/03/2019
实际学习开始日期: 01/09/2017
预计主要完成日期: 04/30/2017
预计完成日期: 10/31/2017

状况或疾病

Gynecologic Neoplasms
Cognition Disorders

干预/治疗

Behavioral: Emerging from the Haze class

-

手臂组

干预/治疗
Experimental: Emerging from the Haze class
A 6-week psycho-educationally-based, cognitive behavioral program to help patients with subjective cognitive complaints after cancer treatment, titled Emerging from the Haze™ (Haze). Each series meets once a week for 2-2.5 hours for 6 weeks.
Behavioral: Emerging from the Haze class
A 6-week class designed to combat chemotherapy-induced cognitive dysfunction. Patients will report symptoms at 6 months and 1 year after the end of their Haze class.

资格标准

有资格学习的年龄 18 Years 至 18 Years
有资格学习的性别Female
接受健康志愿者
标准

Inclusion Criteria:

- Diagnosis of any stage gynecologic cancer including ovarian, uterine/endometrial, cervical, vulvar, and vaginal cancer

- Treated with chemotherapy solely or in combination with surgery, radiation, and/or hormonal therapy

- Female, age ≥ 18 years.

- FACT-Cog score < 59 on the PCI sub scale

- Eligible after 2 months (60 ±5 days) of completing all their active cancer treatment with the exception of long-term hormonal treatments

- Subjective complaint of cognitive concerns at time of enrollment

- Must be able to understand and communicate proficiently in English

- Ability to understand and the willingness to sign a written informed consent.

- Agree to complete study surveys

Exclusion Criteria:

- Patients who have significant personality disorders or unstable psychiatric disorders (including active major depression, substance abuse, psychosis or bipolar disorder) as assessed by the interviewing clinician

- Patients with known brain metastases, history of brain metastases or radiation to the brain.

- Patients with a history of stroke or other pre-existing neurological condition that may contribute to cognitive dysfunction.

- Non-English speakers

- Receiving treatment for another malignancy other than breast cancer

- Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, chronic anemia, uncontrolled hypothyroidism, symptomatic congestive heart failure, unstable angina pectoris, uncontrolled cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements.

结果

主要结果指标

1. The Functional Assessment of Cancer Therapy- Cognition (FACT-Cog) Survey [First day of class (baseline), last day of class (6 weeks), 6 months and 1 year after class]

Measure the change in score from baseline to each of three time points: last day of class (6 weeks), 6 months, and 1 year after class

次要成果指标

1. Patient Reported Outcomes Measurement Information System (PROMIS) - Cognition and General Concerns Survey [First day of class (baseline), last day of class (6 weeks), 6 months and 1 year after class]

Measure the change in score from baseline to each of three time points: last day of class (6 weeks), 6 months, and 1 year after class

2. UCLA Loneliness Scale Survey [First day of class (baseline), last day of class (6 weeks), 6 months and 1 year after class]

Measure the change in score from baseline to each of three time points: last day of class (6 weeks), 6 months, and 1 year after class

其他成果措施

1. Comparison of trainee-taught vs non-trainee taught class [First day of class (baseline), last day of class (6 weeks)]

To compare the impact of a trainee-taught Emerging from the Haze course on gynecologic cancer survivors' self report of cognitive changes based on change of the FACT-Cog compared to the impact of an ongoing non-trainee-taught Emerging from the Haze course on breast cancer survivors' self report of cognitive changes based on the change in FACT-Cog score from first day of class (baseline) to last day of class (6 weeks) in these two groups

加入我们的脸书专页

科学支持的最完整的草药数据库

  • 支持55种语言
  • 科学支持的草药疗法
  • 通过图像识别草药
  • 交互式GPS地图-在位置标记草药(即将推出)
  • 阅读与您的搜索相关的科学出版物
  • 通过药效搜索药草
  • 组织您的兴趣并及时了解新闻研究,临床试验和专利

输入症状或疾病,并阅读可能有用的草药,输入草药并查看所使用的疾病和症状。
*所有信息均基于已发表的科学研究

Google Play badgeApp Store badge